STAT3 activation by catalpol promotes osteogenesis-angiogenesis coupling, thus accelerating osteoporotic bone repair

Abstract

Background Bone fracture repair has gained a lot of attention due to the high incidence of delayed union or even nonunion especially in osteoporotic patients, resulting in a dreadful impact on the quality of life. However, current therapies involve the costly expense and hence become unaffordable strategies for fracture recovery. Herein, developing new strategies for better bone repair is essential and urgent. Catalpol treatment has been reported to attenuate bone loss and promote bone formation. However, the mechanisms underlying its effects remain unraveled. Methods Rat bone marrow mesenchymal stem cells (BMSCs) were isolated from rat femurs. BMSC osteogenic ability was assessed using ALP and ARS staining, immunofluorescence, and western blot analysis. BMSC-mediated angiogenic potentials were determined using the western blot analysis, ELISA testing, scratch wound assay, transwell migration assay, and tube formation assay. To investigate the molecular mechanism, the lentivirus transfection was used. Ovariectomized and sham-operated rats with calvaria defect were analyzed using micro-CT, H&E staining, Masson’s trichrome staining, microfil perfusion, sequential fluorescent labeling, and immunohistochemistry assessment after administrated with/without catalpol. Results Our results manifested that catalpol enhanced BMSC osteoblastic differentiation and promoted BMSC-mediated angiogenesis in vitro. More importantly, this was conducted via the JAK2/STAT3 pathway, as knockdown of STAT3 partially abolished beneficial effects in BMSCs. Besides, catalpol administration facilitated bone regeneration as well as vessel formation in an OVX-induced osteoporosis calvarial defect rat model. Conclusions The data above showed that catalpol could promote osteogenic ability of BMSC and BMSC-dependent angiogenesis through activation of the JAK2/STAT3 axis, suggesting it may be an ideal therapeutic agent for clinical medication of osteoporotic bone fracture.

PPARβ/δ accelerates bone regeneration in diabetic mellitus by enhancing AMPK/mTOR pathway-mediated autophagy

“…Following μCT analysis, the samples were decalcified with 10% EDTA for 4 weeks. Sections of 4.5 μm were prepared using a conventional method [ 31 ]. H&E and Masson trichrome staining (Solarbio, Beijing, China) were performed as the manufacturer’s instruction.…”

Silibinin Promotes Bone Regeneration Through HIF-1α/VEGF and Notch Signaling Pathway in Ovariectomized Rats

“…What's more, the decreased signaling pathway by ovariectomy was restored by SIL treatment. Recently, a large body and animal of emerging evidence has proved that angiogenesis plays a key role in bone repair [31,32]. Previous reports reached consensus that the tightly coupled angiogenesis and osteogenesis play an important role in bone regeneration [33].…”

Valproic Acid Accelerates Bone Repair via Activating Notch Signaling Pathway in Ovariectomized Rats

“…Recently, studies indicated that notch signaling also plays a vital role in mineralization of bone tissue via a direct regulation effect on osteoblastic activit [30,31]. Besides, a large body and animal of emerging evidence has proved that angiogenesis plays a key role in bone repair [32,33]. Similarly, angiogenesis and Osteogenesis were regulated by a variety of growth factors, such as VEGFA and BMP-2 [34,35].…”